Enclomiphene vs TRT: which should I consider first?

Short answer

• If you want to preserve or improve fertility (or plan to father children soon) — try a gonadotropin‑stimulating approach first (enclomiphene or the commonly used off‑label alternative, clomiphene).
• If you have primary testicular failure (high LH/FSH), need rapid and reliable symptom control, or don’t care about fertility — testosterone replacement therapy (TRT) is usually the better first choice.

Why they work differently

• Enclomiphene (the trans‑isomer of clomiphene; studied as “Androxal”) and clomiphene citrate (Clomid, off‑label in men) are oral selective estrogen receptor modulators (SERMs). They increase LH and FSH from the pituitary so the testes make more testosterone and sperm. Good for secondary hypogonadism (low T with low/normal LH) and for men who want to maintain/improve fertility.
• TRT (topical gels like AndroGel/Testim/Axiron, injections like Depo‑Testosterone/testosterone cypionate or Aveed [long‑acting testosterone undecanoate], subcutaneous pellets like Testopel) provides exogenous testosterone. It reliably raises serum T and relieves symptoms, but suppresses LH/FSH and usually reduces sperm production (can cause infertility).

When to consider enclomiphene / clomiphene first

• You have low morning testosterone confirmed on repeat testing and LH is low/normal (secondary hypogonadism).
• You want to preserve or improve fertility or are actively trying to conceive.
• You prefer an oral option and want to stimulate endogenous production rather than taking exogenous hormones.
• Be aware: enclomiphene availability can be limited; clomiphene (Clomid) is widely available and commonly used off‑label with similar clinical goals.

When TRT is more appropriate first

• You have primary hypogonadism (high LH/FSH) — SERMs are unlikely to help because the testes can’t respond.
• You need faster or more consistent symptom control (energy, libido, muscle mass), or previous SERM therapy failed or was not tolerated.
• You do not want future fertility — or you accept using sperm banking before starting TRT.

Risks and monitoring

• SERMs (enclomiphene/clomiphene): possible mood changes, visual disturbances, gynecomastia; usually preserve/increase sperm count. Monitor T, LH/FSH, liver tests occasionally, and symptoms.
• TRT: risks include erythrocytosis (monitor hematocrit), acne, worsening sleep apnea, possible effect on cardiovascular risk (data mixed), and suppression of sperm production. Monitor testosterone, hematocrit, PSA, lipids, and symptoms per guidelines.

Practical steps to take now

1. Get a full baseline evaluation: two morning total (and free if available) testosterone measurements, LH, FSH, prolactin, CBC, PSA (if age appropriate), metabolic panel, SHBG if needed.
2. Discuss fertility plans. If you want children, prioritize SERM/enclomiphene/clomiphene or referral to reproductive urology.
3. If labs show primary hypogonadism, or if you want immediate symptom control and accept fertility loss, discuss TRT options (gels, injections, long‑acting injections or pellets) with an endocrinologist or urologist.
4. If you prefer a trial of a SERM, ask about availability of enclomiphene in your area and about clomiphene (Clomid) as an effective, lower‑cost off‑label option. If considering TRT, discuss brands/routes (AndroGel, Testim, Depo‑Testosterone, Aveed, Testopel) and monitoring schedule.

Who to see

• Start with your primary care doctor, endocrinologist, or a urologist who treats male reproductive health. If fertility is a priority, a reproductive urologist or fertility specialist is best.

If you want, tell me:

• Your age, desire for future fertility, recent morning testosterone value(s), and LH/FSH results (if you have them) — I can give a more tailored recommendation.